Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin
Yingwei
Zhang
*a,
Zeyu
Zhang
b,
Chundi
Li
a,
Donge
Tang
b and
Yong
Dai
*b
aDepartment of Nephrology, Shenzhen Longhua District Central Hospital, Shenzhen 518000, China. E-mail: 18653133290zyw@sina.com; Tel: +86-18565668800
bThe Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen 518020, China. E-mail: daiyong22@163.com; Tel: +86-0755-22942780
First published on 18th April 2023
Abstract
Correction for ‘Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin’ by Yingwei Zhang et al., Mol. Omics, 2022, 18, 643–651, https://doi.org/10.1039/D2MO00036A.
The authors regret that the institution for one of the authors, Yingwei Zhang, was given incorrectly. The corrected affiliation for this paper is as shown above.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2023 |